Lv4
640 积分 2024-06-11 加入
A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities
7天前
已完结
Non-viral delivery of RNA for therapeutic T cell engineering
1个月前
已完结
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis
6个月前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
6个月前
已关闭
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
6个月前
已完结
CD16A-Specific Tetravalent Bispecific Immune Cell Engagers Potently Induce Antibody-Dependent Cellular Phagocytosis (ADCP) on Macrophages
6个月前
已关闭
Exploring the NK cell platform for cancer immunotherapy
6个月前
已完结
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
6个月前
已完结
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
7个月前
已完结
CAR T cell combination therapies to treat cancer
7个月前
已完结
皖公网安备34019202002308
